Allan Bradley
Chief Executive Officer
NT
Neuritek Therapeutics Inc.
The startup is developing mechanism-based treatments for post-traumatic stress disorder (PTSD) using targeted pharmacological approaches to address the underlying neurobiological mechanisms of the condition. Their focus is on improving the quality of life for patients and families affected by psychiatric disorders through effective mental health interventions.
- Biotechnology
- Digital Health
- Healthcare Technology
Updated 6 months ago
Funding
Raised to date
$27.7MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
William Hapworth
Founder & Chairman
Product
Features
- The startup is developing mechanism-based treatments for post-traumatic stress disorder (PTSD) using targeted pharmacological approaches to address the underlying neurobiological mechanisms of the condition. Their focus is on improving the quality of life for patients and families affected by psychiatric disorders through effective mental health interventions.